drugset / Trial / NCT00767806

A Study for Patient With Chronic Low Back Pain

NCT00767806

Phase 3 Completed 401 enrolled Eli Lilly and Company
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if duloxetine reduces the severity of chronic low back pain.

Timeline

Start
2008-09
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg Oral

Indications